 | • レポートコード：QYR9NV18486 • 出版社/出版日：QYResearch / 2019年11月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、血栓溶解薬の世界市場について調査・分析し、血栓溶解薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（フィブリン特異的薬物、非フィブリン特異的薬物シブ、シムツズマブ、INCB-39110、その他）、用途別（病院薬局、小売薬局、電子薬局）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の血栓溶解薬市場動向 ・主要企業別マーケットシェア ・血栓溶解薬の種類別市場規模2014-2019 （フィブリン特異的薬物、非フィブリン特異的薬物シブ、シムツズマブ、INCB-39110、その他） ・血栓溶解薬の用途別市場規模2014-2019 （病院薬局、小売薬局、電子薬局） ・血栓溶解薬の北米市場：主要企業・種類別/用途別市場規模 ・血栓溶解薬のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・血栓溶解薬の中国市場：主要企業・種類別/用途別市場規模 ・血栓溶解薬の日本国内市場：主要企業・種類別/用途別市場規模 ・血栓溶解薬の東南アジア市場：主要企業・種類別/用途別市場規模 ・血栓溶解薬のインド市場：主要企業・種類別/用途別市場規模 ・血栓溶解薬の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Roche、Sedico Pharmaceuticals、Eumedica、Genentech、Microbix、Medac、Mochida Pharmaceutical、Taj Pharmaceuticals、Wulfing Pharma GmbH） ・血栓溶解薬の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Thrombolytic drugs, which dissolve solid blood clots, are commonly used to treat clot complications such as acute myocardial infarction, pulmonary embolism, deep venous thrombosis, blocked catheters, and acute ischemic stroke.Urokinase, streptokinase and tissue plasminogen activator (tPA) are the basic thrombolytic agents available on the market for thrombolytic therapy.Divided into fibrin – specific drugs and non – fibrin – specific drugs.The fibrin-specific drug segment is further divided into tissue plasminogen activator, retiplase, tenaiplase, etc.Nonfibrin-specific drugs are subdivided into urokinase, streptokinase, and plasminogen activated complexes.In 2018, the global Thrombolytic Drug market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Thrombolytic Drug status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Thrombolytic Drug development in North America, Europe, China and Japan.
The key players covered in this study
Roche
Sedico Pharmaceuticals
Eumedica
Genentech
Microbix
Medac
Mochida Pharmaceutical
Taj Pharmaceuticals
Wulfing Pharma GmbH
Market segment by Type, the product can be split into
Fibrin Specific Drugs
Nonfibrin-specific Drugs
Market segment by Application, split into
Hospital Pharmacy
Retail Pharmacies
Electronic Pharmacy
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
The study objectives of this report are:
To analyze global Thrombolytic Drug status, future forecast, growth opportunity, key market and key players.
To present the Thrombolytic Drug development in North America, Europe, China and Japan.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Thrombolytic Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Thrombolytic Drug Market Size Growth Rate by Type (2014-2025)
1.4.2 Fibrin Specific Drugs
1.4.3 Nonfibrin-specific Drugs
1.5 Market by Application
1.5.1 Global Thrombolytic Drug Market Share by Application (2019-2025)
1.5.2 Hospital Pharmacy
1.5.3 Retail Pharmacies
1.5.4 Electronic Pharmacy
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Thrombolytic Drug Market Size
2.2 Thrombolytic Drug Growth Trends by Regions
2.2.1 Thrombolytic Drug Market Size by Regions (2019-2025)
2.2.2 Thrombolytic Drug Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
3.1 Thrombolytic Drug Market Size by by Players
3.1.1 Global Thrombolytic Drug Revenue by by Players (2014-2019)
3.1.2 Global Thrombolytic Drug Revenue Market Share by by Players (2014-2019)
3.1.3 Global Thrombolytic Drug Market Concentration Ratio (CR5 and HHI)
3.2 Thrombolytic Drug Key Players Head office and Area Served
3.3 Key Players Thrombolytic Drug Product/Solution/Service
3.4 Date of Enter into Thrombolytic Drug Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Thrombolytic Drug Market Size by Type (2014-2019)
4.2 Global Thrombolytic Drug Market Size by Application (2014-2019)
5 North America
5.1 North America Thrombolytic Drug Market Size (2014-2019)
5.2 Thrombolytic Drug Key Players in North America
5.3 North America Thrombolytic Drug Market Size by Type
5.4 North America Thrombolytic Drug Market Size by Application
6 Europe
6.1 Europe Thrombolytic Drug Market Size (2014-2019)
6.2 Thrombolytic Drug Key Players in Europe
6.3 Europe Thrombolytic Drug Market Size by Type
6.4 Europe Thrombolytic Drug Market Size by Application
7 China
7.1 China Thrombolytic Drug Market Size (2014-2019)
7.2 Thrombolytic Drug Key Players in China
7.3 China Thrombolytic Drug Market Size by Type
7.4 China Thrombolytic Drug Market Size by Application
8 Japan
8.1 Japan Thrombolytic Drug Market Size (2014-2019)
8.2 Thrombolytic Drug Key Players in Japan
8.3 Japan Thrombolytic Drug Market Size by Type
8.4 Japan Thrombolytic Drug Market Size by Application
9 International Players Profiles
9.1 Roche
9.1.1 Roche Company Details
9.1.2 Company Description and Business Overview
9.1.3 Thrombolytic Drug Introduction
9.1.4 Roche Revenue in Thrombolytic Drug Business (2014-2019))
9.1.5 Roche Recent Development
9.2 Sedico Pharmaceuticals
9.2.1 Sedico Pharmaceuticals Company Details
9.2.2 Company Description and Business Overview
9.2.3 Thrombolytic Drug Introduction
9.2.4 Sedico Pharmaceuticals Revenue in Thrombolytic Drug Business (2014-2019)
9.2.5 Sedico Pharmaceuticals Recent Development
9.3 Eumedica
9.3.1 Eumedica Company Details
9.3.2 Company Description and Business Overview
9.3.3 Thrombolytic Drug Introduction
9.3.4 Eumedica Revenue in Thrombolytic Drug Business (2014-2019)
9.3.5 Eumedica Recent Development
9.4 Genentech
9.4.1 Genentech Company Details
9.4.2 Company Description and Business Overview
9.4.3 Thrombolytic Drug Introduction
9.4.4 Genentech Revenue in Thrombolytic Drug Business (2014-2019)
9.4.5 Genentech Recent Development
9.5 Microbix
9.5.1 Microbix Company Details
9.5.2 Company Description and Business Overview
9.5.3 Thrombolytic Drug Introduction
9.5.4 Microbix Revenue in Thrombolytic Drug Business (2014-2019)
9.5.5 Microbix Recent Development
9.6 Medac
9.6.1 Medac Company Details
9.6.2 Company Description and Business Overview
9.6.3 Thrombolytic Drug Introduction
9.6.4 Medac Revenue in Thrombolytic Drug Business (2014-2019)
9.6.5 Medac Recent Development
9.7 Mochida Pharmaceutical
9.7.1 Mochida Pharmaceutical Company Details
9.7.2 Company Description and Business Overview
9.7.3 Thrombolytic Drug Introduction
9.7.4 Mochida Pharmaceutical Revenue in Thrombolytic Drug Business (2014-2019)
9.7.5 Mochida Pharmaceutical Recent Development
9.8 Taj Pharmaceuticals
9.8.1 Taj Pharmaceuticals Company Details
9.8.2 Company Description and Business Overview
9.8.3 Thrombolytic Drug Introduction
9.8.4 Taj Pharmaceuticals Revenue in Thrombolytic Drug Business (2014-2019)
9.8.5 Taj Pharmaceuticals Recent Development
9.9 Wulfing Pharma GmbH
9.9.1 Wulfing Pharma GmbH Company Details
9.9.2 Company Description and Business Overview
9.9.3 Thrombolytic Drug Introduction
9.9.4 Wulfing Pharma GmbH Revenue in Thrombolytic Drug Business (2014-2019)
9.9.5 Wulfing Pharma GmbH Recent Development
10 Market Forecast 2019-2025
10.1 Market Size Forecast by Product (2019-2025)
10.2 Market Size Forecast by Application (2019-2025)
10.3 Market Size Forecast by Regions
10.4 North America
10.5 Europe
10.6 China
10.7 Japan
11 Analyst’s Viewpoints/Conclusions
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Disclaimer
12.3 Author Details
Table Thrombolytic Drug Key Market Segments
Table Key Players Thrombolytic Drug Covered
Table Global Thrombolytic Drug Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Fibrin Specific Drugs Figures
Table Key Players of Fibrin Specific Drugs
Figuer Nonfibrin-specific Drugs Figures
Table Key Players of Nonfibrin-specific Drugs
Table Global Thrombolytic Drug Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Thrombolytic Drug Market Share by Application in 2018 & 2025
Figure Hospital Pharmacy Case Studies
Figure Retail Pharmacies Case Studies
Figure Electronic Pharmacy Case Studies
Figure Thrombolytic Drug Report Years Considered
Figure Global Thrombolytic Drug Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Thrombolytic Drug Market Size by Regions 2019-2025 (Million US$)
Table Global Thrombolytic Drug Market Size by Regions 2019-2025 (Million US$)
Table Global Thrombolytic Drug Market Share by Regions 2014-2019
Figure Global Thrombolytic Drug Market Share by Regions 2014-2019
Figure Global Thrombolytic Drug Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Thrombolytic Drug Revenue by by Players (2014-2019) (Million US$)
Table Global Thrombolytic Drug Market Share by by Players (2014-2019)
Figure Global Thrombolytic Drug Market Share by by Players in 2018
Table Global Thrombolytic Drug by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Thrombolytic Drug Product/Solution/Service
Table Date of Enter into Thrombolytic Drug Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Thrombolytic Drug Market Size by Type (2014-2019) (Million US$)
Table Global Thrombolytic Drug Market Size Share by Type (2014-2019)
Figure Global Thrombolytic Drug Market Size Market Share by Type (2014-2019)
Table Global Thrombolytic Drug Market Size by Application (2014-2019) (Million US$)
Table Global Thrombolytic Drug Market Size Share by Application (2014-2019)
Figure Global Thrombolytic Drug Market Size Market Share by Application (2014-2019)
Figure Global Thrombolytic Drug Revenue Market Share by Application in 2018
Figure North America Thrombolytic Drug Market Size 2014-2019 (Million US$)
Table North America Key Players Thrombolytic Drug Revenue (2018-2019) (Million US$)
Table North America Key Players Thrombolytic Drug Market Share (2018-2019)
Table North America Thrombolytic Drug Market Size by Type 2014-2019 (Million US$)
Table North America Thrombolytic Drug Market Share by Type 2014-2019
Table North America Thrombolytic Drug Market Size by Application 2014-2019 (Million US$)
Table North America Thrombolytic Drug Market Share by Application 2014-2019
Figure Europe Thrombolytic Drug Market Size 2014-2019 (Million US$)
Table Europe Key Players Thrombolytic Drug Revenue (2018-2019) (Million US$)
Table Europe Key Players Thrombolytic Drug Market Share (2018-2019)
Table Europe Thrombolytic Drug Market Size by Type 2014-2019 (Million US$)
Table Europe Thrombolytic Drug Market Share by Type 2014-2019
Table Europe Thrombolytic Drug Market Size by Application 2014-2019 (Million US$)
Table Europe Thrombolytic Drug Market Share by Application 2014-2019
Figure China Thrombolytic Drug Market Size 2014-2019 (Million US$)
Table China Key Players Thrombolytic Drug Revenue (2018-2019) (Million US$)
Table China Key Players Thrombolytic Drug Market Share (2018-2019)
Table China Thrombolytic Drug Market Size by Type 2014-2019 (Million US$)
Table China Thrombolytic Drug Market Share by Type 2014-2019
Table China Thrombolytic Drug Market Size by Application 2014-2019 (Million US$)
Table China Thrombolytic Drug Market Share by Application 2014-2019
Figure Japan Thrombolytic Drug Market Size 2014-2019 (Million US$)
Table Japan Key Players Thrombolytic Drug Revenue (2018-2019) (Million US$)
Table Japan Key Players Thrombolytic Drug Market Share (2018-2019)
Table Japan Thrombolytic Drug Market Size by Type 2014-2019 (Million US$)
Table Japan Thrombolytic Drug Market Share by Type 2014-2019
Table Japan Thrombolytic Drug Market Size by Application 2014-2019 (Million US$)
Table Japan Thrombolytic Drug Market Share by Application 2014-2019
Table Roche Company Details
Table Roche Revenue in Thrombolytic Drug Business 2014-2019 (Million US$)
Figure Roche Revenue Growth Rate in Thrombolytic Drug Business (2014-2019)
Table Roche Recent Development
Table Sedico Pharmaceuticals Company Details
Table Sedico Pharmaceuticals Revenue in Thrombolytic Drug Business 2014-2019 (Million US$)
Figure Sedico Pharmaceuticals Revenue Growth Rate in Thrombolytic Drug Business (2014-2019)
Table Sedico Pharmaceuticals Recent Development
Table Eumedica Company Details
Table Eumedica Revenue in Thrombolytic Drug Business 2014-2019 (Million US$)
Figure Eumedica Revenue Growth Rate in Thrombolytic Drug Business (2014-2019)
Table Eumedica Recent Development
Table Genentech Company Details
Table Genentech Revenue in Thrombolytic Drug Business 2014-2019 (Million US$)
Figure Genentech Revenue Growth Rate in Thrombolytic Drug Business (2014-2019)
Table Genentech Recent Development
Table Microbix Company Details
Table Microbix Revenue in Thrombolytic Drug Business 2014-2019 (Million US$)
Figure Microbix Revenue Growth Rate in Thrombolytic Drug Business (2014-2019)
Table Microbix Recent Development
Table Medac Company Details
Table Medac Revenue in Thrombolytic Drug Business 2014-2019 (Million US$)
Figure Medac Revenue Growth Rate in Thrombolytic Drug Business (2014-2019)
Table Medac Recent Development
Table Mochida Pharmaceutical Company Details
Table Mochida Pharmaceutical Revenue in Thrombolytic Drug Business 2014-2019 (Million US$)
Figure Mochida Pharmaceutical Revenue Growth Rate in Thrombolytic Drug Business (2014-2019)
Table Mochida Pharmaceutical Recent Development
Table Taj Pharmaceuticals Company Details
Table Taj Pharmaceuticals Revenue in Thrombolytic Drug Business 2014-2019 (Million US$)
Figure Taj Pharmaceuticals Revenue Growth Rate in Thrombolytic Drug Business (2014-2019)
Table Taj Pharmaceuticals Recent Development
Table Wulfing Pharma GmbH Company Details
Table Wulfing Pharma GmbH Revenue in Thrombolytic Drug Business 2014-2019 (Million US$)
Figure Wulfing Pharma GmbH Revenue Growth Rate in Thrombolytic Drug Business (2014-2019)
Table Wulfing Pharma GmbH Recent Development
Table Global Thrombolytic Drug Market Size by Regions (Million US$) 2019-2025
Figure Global Thrombolytic Drug Market Size Share by Regions (2019-2025)
Figure Global Thrombolytic Drug Market Size Share by Regions in 2025
Figure North America Thrombolytic Drug Market Size Forecast (2019-2025)(Million USD)
Figure Europe Thrombolytic Drug Market Size Forecast (2019-2025)(Million USD)
Figure China Thrombolytic Drug Market Size Forecast (2019-2025)(Million USD)
Figure Japan Thrombolytic Drug Market Size Forecast (2019-2025)(Million USD)
Table Global Thrombolytic Drug Market Size by Product (2019-2025) (Million US$)
Figure Global Thrombolytic Drug Market Size by Product (2019-2025)
Figure Global Thrombolytic Drug Market Size by Product in 2025
Table Global Thrombolytic Drug Market Size by Application (2019-2025) (Million US$)
Figure Global Thrombolytic Drug Market Size by Application (2019-2025)
Figure Global Thrombolytic Drug Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
血栓溶解療法のグローバル市場：規模・現状・予測2019-2025 Blood clots are one of the most serious complications in the body.When blood clots, major arteries or veins become blocked, which stops normal blood flow.The cessation of normal blood flow can cause bleeding and often leads to heart attacks and strokes.Thrombolytic therapy is a treatment in which so…- 部位特異的薬液送達の世界市場予測 2023年：メーカー別、地域別、種類・用途別 The selective delivery of chemotherapeutic agents to their site of action should increase therapeutic effectiveness and limit side effects. Most drug therapies currently available, however, exhibit little, if any specificity. Many times, a drug has limited or no access to its intended site of action…
- 腫瘍特異抗原のグローバル市場：規模・現状・予測2019-2025 Tumor-specific Antigen is a new Antigen that is expressed on the surface of certain Tumor cells but not on normal cells.Such antigens may be present in tumors of the same tissue type in different individuals.Tumor-specific antigens help the body develop an immune response to cancer cells.They could …
- クリプトコッカス薬のグローバル市場：規模・現状・予測2019-2025 Cryptococcosis is a fungal disease.It is caused by Cryptococcus neococcus, or Cryptococcus gattii.The disease is spread by inhaling a fungus linked to birds.It can infect animals and humans.It infects humans by inhaling fungus.The fungus mainly affects the lungs, but it can spread to the brain, call…
- 体部白癬用薬のグローバル市場：規模・現状・予測2019-2025 Tinea corporis, also known as ringworm, is a superficial fungal infection (dermatophytosis) of the arms and legs, especially on glabrous skin; however, it may occur on any part of the body. It is similar to other forms of tinea.In 2018, the global Tinea Corporis Drugs market size was xx million US$ …